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Interneuron dysfunction in humans is often associated with neuro-
logical and psychiatric disorders, such as epilepsy, schizophrenia,
and autism. Some of these disorders are believed to emerge during
brain formation, at the time of interneuron speciﬁcation, migration,
and synapse formation. Here, using a mouse model and a host of his-
tological and molecular biological techniques, we report that the sig-
naling molecule cyclin-dependent kinase 5 (Cdk5), and its activator
p35, control the tangential migration of interneurons toward and
within the cerebral cortex by modulating the critical neurodevelop-
mental signaling pathway, ErbB4/phosphatidylinositol 3-kinase, that
has been repeatedly linked to schizophrenia. This ﬁnding identiﬁes
Cdk5 as a crucial signaling factor in cortical interneuron develop-
ment in mammals.
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Introduction
Dysfunction of cerebral cortical interneurons, which may stem
from their abnormal development and migration, has been im-
plicated in the etiology of a number of neurological and psy-
chiatric disorders in humans, such as epilepsy, schizophrenia,
and autism (Marín 2012). In recent years, genetically manipu-
lated mouse models have been shown to faithfully mimic
many of the molecular, biological, and clinical features of
human brain pathologies and, also, revealed the source and
migratory behavior of different types of neurons. Speciﬁcally,
it has been found that interneurons of the cerebral cortex (Cx)
originate mainly from the subcortical ganglionic eminence
(GE) and follow a long journey to their ﬁnal destinations in the
Cx. Initially, interneurons travel in multiple tangential streams,
before turning radially to settle in the correct layer. Evidence
suggests that their migration relies on the dynamics of the
branched leading processes that efﬁciently modify their orien-
tation in response to extracellular guidance cues (Ang et al.
2003; Métin et al. 2006; Marin et al. 2010). However, little is
known about the signaling molecules, linking external gui-
dance cues, and cytoskeletal responses, crucial for proper
interneuron migration into the Cx.
Cdk5, a versatile proline-directed serine/threonine kinase,
and its main activator p35, are signaling molecules expressed
in neurons of the developing Cx (Dhavan and Tsai 2001).
p35/Cdk5 kinase is vital for radial glia-guided locomotion
and laminar fate of pyramidal neurons by phosphorylating
intracellular substrates associated with the cytoskeleton
(Govek et al. 2011). Some have suggested that Cdk5 is not in-
volved in interneuron migration, as it does not appear to
control their layer acquisition (Gilmore and Herrup 2001;
Hammond et al. 2004). However, our earlier work clearly in-
dicated that p35/Cdk5 regulates cortical interneuron direc-
tionality and leading process branched morphology, during
their tangential phase of migration, in a cell-autonomous
manner (Rakic´ et al. 2009). Here, we aimed to identify Cdk5
substrates solely expressed in cortical interneurons and
associated with their migration in order to establish the
speciﬁc role of p35/Cdk5 in these cells.
ErbB (v-erb-a erythroblastic leukemia viral oncogene
homolog) proteins (1–4) are members of the tyrosine protein
kinase family and the epidermal growth factor (EGF) receptor
subfamily. ErbBs interact with ligands of the EGF superfamily,
including neuregulins (NRGs), dimerize, catalytically activate
each other by cross-phosphorylation, and then stimulate
various signaling pathways. ErbB4, the only ErbB member
with multiple isoforms (Junttila et al. 2000), mediates cell
migration (Golding et al. 2000; Anton et al. 2004; Sakakibara
and Horwitz 2006) via phosphatidylinositol (PI) 3-kinase
pathway (Kainulainen et al. 2000; Gambarotta et al. 2004). In
the forebrain, ErbB4 expression and function have been con-
strained to a subpopulation of migrating cortical interneurons
(Yau et al. 2003; Flames et al. 2004; Li et al. 2012) that largely
differentiate into fast-spiking, parvalbumin (PV)-positive cells
(Marín 2012).
Here, we report that p35/Cdk5 directs tangential migration
of cortical interneurons by regulating the ErbB4/PI3-kinase
signaling pathway at the pallial/subpallial border (PSB). We
ﬁrst showed that the Cyt1 isoform of ErbB4, coupled to PI3-
kinase, emerges when interneurons reach the PSB and enter
the Cx streaming toward sources of ErbB4 ligands (i.e., NRG1,
NRG3, and heparin-binding EGF (HB-EGF)). We then ident-
iﬁed ErbB4 as a novel p35/Cdk5 kinase substrate, and demon-
strated that Cdk5 is an upstream regulator of ErbB4/PI3-kinase
signaling by positively controlling tyrosine phosphorylation of
the PI3-kinase docking site Y1056. Further, we found that
Cdk5-dependent ErbB4/PI3-kinase signaling cascade regulates
interneuron polarity, directionality, and leading process mor-
phology at the PSB. Finally, we showed that lack of Cdk5
activity in p35 knockout mice (KO) leads to permanent
reduction in the ﬁnal number of a subtype of interneurons
(i.e., PV- and somatostatin (SST)-positive) that may affect neur-
onal circuit formation, thus increasing the risk of neurodeve-
lopmental disorders, such as schizophrenia.
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Materials and Methods
Mouse Lines
p35, Cdk5, GAD67-GFP (Δneo), ErbB4HER4heart, and ErbB4HETmice
were used in this study (see Supplementary material). All procedures
were performed under license, and in accordance to regulations of the
UK Home Ofﬁce, Japan Neuroscience Society and Keio University
School of Medicine.
Fluorescence-Activated Cell Sorting (FACS) of GFPGAD67(+) Cells
GABAergic (GFP-positive) and non-GABAergic (GFP-negative) cells,
from Cx and GE of GAD67-GFP transgenic mice at E13.5 and E15.5
were isolated by FACS method as described previously (Faux et al.
2010).
Cell Lines and Transfection
COS7 cells were transfected with expression vectors using Lipofecta-
mine 2000 reagent (Invitrogen) according to manufacturer’s protocol,
and collected after 48 h.
RT-PCR, Microarray, Immunohistochemistry, Immunoblotting,
and Kinase Assay
Standard techniques were used for these analyses and are described in
detail in Supplementary material, as well as the sources of antibodies
and reagents.
Phospho-ErbB4-Thr1152 Antibody
Phosphorylation state-speciﬁc polyclonal antibody (ab) that speciﬁ-
cally recognizes phosphorylated ErbB4 at Thr1152 was generated and
puriﬁed by Sigma-Genosys (Haverhill, UK) using a rat peptide se-
quence CELDEEGYM[pThr]PMHDK conjugated to carrier protein KLH
injected as antigen in rabbits.
Cloning and Site-Directed Mutagenesis
JMa-Cyt1 (referred to as Cyt1) and JMa-Cyt2 (referred to as Cyt2) iso-
forms of ErbB4, as well as ErbB4ΔICD-JMa (referred to as ErbB4ΔICD),
truncated for most of the intracellular domain (ICD), were cloned from a
rat adult forebrain cDNA library (see Supplementary material). Cyt1
(accession number AY375306.1) and Cyt2 (accession number
AY375307.1), submitted to the GenBank by Gambarotta et al. in 2003,
entirely matched the sequences obtained in this study. GST-
ErbB4Ala1143-Tyr1262, containing T1152 (referred to as GST-T1152), was
cloned using Cyt1 as a template. Nrg3 (exons 2, 3, 4+CAG+5), encoding
the full EGF-like domain, was cloned from a mouse E12.5 embryo cDNA
library.
A single-point mutation in the Cdk5 phosphorylation [T1152 (ACT)
to A (GCT)] or PI3-kinase-binding site [Y1056 (TAC) to F (TTC)] of
ErbB4 or multiple point mutations within the EGF-like domain of Nrg3
[referred as to Nrg3mut: C1 (TGT) to G (GGT), C2 (TGT) to F (TTT), C6
(TGT) to G (GGT), and conserved R (CGT) before C6 to P (CCT)] were
introduced using a standard QuikChangeR II XL Site-Directed Muta-
genesis Kit (Agilent Technologies; see Supplementary material).
Expression Vectors
Cyt1, Cyt2, Cyt1-T1152A, Cyt1-Y1056F, Cyt2-T1152A, and ErbB4ΔICD
were expressed from the mychis B (-) (Invitrogen) or the
pCAG-IRES-EGFP (referred to as pCAG; Kawauchi et al. 2003) vector,
GST-T1152 and GST-T1152A from the pGEX-4T2 (GE Healthcare)
vector, and Nrg3 and Nrg3mut from the pSeqTag2B (Invitrogen)
vector. The pCAG-tdTomato vector was obtained by insertion of tdTo-
mato cDNA from the ptdTomato (Clontech) into the pCAG-MCS2
(Kawauchi et al. 2005) vector.
In Vitro Migration Assays
Chemotactic assay and focal electroporation of MGE followed by
whole telencephalic hemisphere culture were performed as reported
previously (Kanatani et al. 2008; Rakic´ et al. 2009) and are described in
detail in Supplementary material.
Quantiﬁcation of Cells in Embryonic and Adult Forebrain
The total number of immunolabeled cells was manually counted using
the MetaMorph software (Molecular Devices). The surface area of the
embryonic MGE or adult somatosensory Cx (including adjacent white
matter) was measured with the Image J (NIH) program.
Statistical Analysis
Data were expressed as mean ± standard error of the mean (SEM) and
evaluated for signiﬁcant differences by means of a 2-tailed Student’s
t-test (Microsoft Excel). Error bars represent SEM.
Results
ErbB4, But Not Other ErbBs, is Expressed by Migrating
Cortical Interneurons
Our aim was to identify substrates of Cdk5 that play a role in
the migration of cortical GABAergic interneurons. The differ-
ential expression of ErbB growth factor receptors, their
ligands, and associated signaling molecules in embryonic (E)
forebrain or its GABAergic and non-GABAergic cells, isolated
from the WTGAD67GFP mice by FACS (Fig. 1A), was ﬁrst ex-
plored, bearing in mind that some ErbBs are Cdk5 substrates
(Fu et al. 2001; Li et al. 2003; Fu et al. 2005), and that ErbB4 is
expressed in migrating interneurons (Yau et al. 2003).
End-point PCR, microarray analyses and immunoblotting
studies revealed the expression of ErbB1, ErbB2, and ErbB4
and very little, if any, ErbB3 in the Cx (Fig. 1B; Supplementary
Table 2 and Fig. 1). However, the GFPGAD67(+) cells, isolated
from tangential cortical migratory streams at E13.5 and sub-
jected to PCR, expressed ErbB4 and no other members of the
ErbB family (Fig. 1B and Supplementary Fig. 1). This ﬁnding
was conﬁrmed in a microarray study targeting all forebrain
interneurons, namely, GE and cortical GFPGAD67(+) cells, at
E13.5 and E15.5 (Faux et al. 2010, Supplementary Table 2). In
addition, immunohistochemistry with ErbB4 ab revealed that
about 3 quarters of all GFPGAD67(+) cortical interneurons
express ErbB4 in either the preplate (PPL; 77%) or intermedi-
ate zone (IZ; 78%) at E13.5 (Fig. 1C–F). In contrast, the
expression of other ErbBs was found in the GFPGAD67(−) corti-
cal cells (Fig. 1B and Supplementary Fig. 1). Finally, the
expression of Cdk5 and its activators p35 and p39 was also ob-
served in the Cx and in GFPGAD67(+) cells (Fig. 1B and Sup-
plementary Table 2).
Three ErbB4 Ligands Facilitate Cortical Interneuron
Migration In Vitro
ErbB4 ligands, namely NRG1, NRG3, and HB-EGF, were abun-
dantly expressed in the noninterneurons (GFPGAD67(−)) of the
developing forebrain (Supplementary Table 2), and, according
to the literature, their topographical distribution was distinct (i.
e., cortical plate and proliferative zones of the pallium, PSB and
striatum of the subpallium; Supplementary Figs 1 and 2). There-
fore, we assessed the effect of these ErbB4 ligands on the
migration of interneurons in an in vitro migration assay. Subjects
of our analysis were either cells derived from E13.5 medial (M)
GE, the site of origin of early-born, ErbB4-expressing inter-
neurons, or Cx. As ErbB3 is hardly expressed in the Cx (Fig. 1B;
Supplementary Fig. 1 and Table 2) and HB-EGF does not facili-
tate chemotaxis via ErbB1 (Elenius et al. 1997), only ErbB4
remains as a recognized receptor for the mediation of the che-
motactic effects of its ligands at that age (Supplementary Fig. 1).
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ErbB4 ligands, like other members of the EGF superfamily,
contain a common EGF-like domain essential for their activity.
This domain has a characteristic structure with 6 cysteine resi-
dues that form 3 intramolecular disulﬁde bonds. Here, we used
either an EGF-like domain of NRG1β and HB-EGF, or con-
ditioned medium (CM) of COS7 cells transfected with a plasmid
encoding the EGF-like domain of NRG3. Following the 6-h long
assay, we noted: ﬁrst, MGE cells migrated toward NRG1β and
HB-EGF in a dose-dependent manner (Fig. 1G and Supplemen-
tary Fig. 1). Second, MGE cells were attracted to NRG3-CM,
which is a signiﬁcant novel ﬁnding, and this action was abol-
ished using either CM of COS7 cells transfected with a plasmid
encoding a mutated EGF-like domain of NRG3 (NRG3mut-CM),
or NRG3-CM treated with a blocking NRG3 ab that speciﬁcally
recognizes the EGF-like domain of the ligand (control-CM:
89 ± 7; NRG3-CM: 124 ± 8; NRG3mut-CM: 68 ± 11; NRG3-CM
+ab: 74 ± 8; Fig. 1G). Finally, the chemotactic response of corti-
cal cells to ErbB4 ligands was peculiarly more robust than that
of MGE cells (control: Cx 69 ± 7 vs. MGE 71 ± 8; NRG1β: Cx
236 ± 8 vs. MGE 160 ± 5; HB-EGF: Cx 165 ± 4 vs. MGE 129 ± 7;
control-CM: Cx 85 ± 5 vs. MGE 89 ± 7; NRG3-CM: Cx 160 ± 7 vs.
MGE 124 ± 8; Fig. 1H). In summary, GABAergic cells are at-
tracted by NRG1, NRG3, and HB-EGF in vitro.
Cortical Interneurons Upregulate Cyt1 Expression
in the Pallium
The signaling mechanisms by which ErbB4 exerts its functions
in cell migration are only partly understood. Unlike other
members of ErbB receptor family, this gene is subject to
Figure 1. ErbB4 and its ligands facilitate migration of cortical interneurons in vitro. (A) Forebrain section of a GAD67GFP mouse embryo, showing areas/cells used in indicated
experiments. GFPGAD67(+) cells represent GABAergic interneurons. (B) RT-PCR. ErbBs, p35, and Cdk5 expression in the developing Cx. Actβ is used as an internal control. (C–F)
Expression of ErbB4 in GFPGAD67(+) cells in the cortical migratory streams. (G, H) Chemotactic response of MGE- and Cx-derived cells to control (white) or to EGF-like domain of
ErbB4 ligands: NRG1β (green), HB-EGF (blue), or NRG3-CM (burgundy). Negative controls for NRG3 (pink): NRG3mut-CM or NRG3-CM treated with a blocking NRG3 ab; (G) MGE
cells; (H) MGE versus Cx cells. *P≤ 0.05, **P≤ 0.01, ***P≤ 0.005, t-test. CM, conditioned medium. Bar, 50 μm.
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differential promoter usage and alternative splicing (Junttila
et al. 2000; Sundvall et al. 2008). On the one hand, extracellular
juxtamembrane (JM) isoforms are either sensitive (JMa) or
resistant (JMb) to proteolytic cleavage (Fig. 2A). On the other,
cytoplasmic isoforms, Cyt1 and Cyt2, differ by the presence
(Cyt1) or absence (Cyt2) of a binding site for PI 3-kinase (tyro-
sine Y1056; Fig. 2A); the coupling of Cyt1 with PI3-kinase/Akt
pathway stimulates chemotaxis (Kainulainen et al. 2000; Gam-
barotta et al. 2004). Here, we observed temporal and spatial
regulation of ErbB4 isoform expression in forebrain inter-
neurons (GFPGAD67(+); Fig. 2B,C). Importantly, GFPGAD67(+)
cells in the GE, but not in the Cx, at E13.5, lacked expression of
the PI3-kinase-binding/chemotaxis-mediating ErbB4 isoform
(Cyt1; Fig. 2C). Accordingly, by using phosphorylation state-
speciﬁc ab, we found that ErbB4 was signiﬁcantly phosphory-
lated on Cyt1-speciﬁc Y1056 in the Cx, but not in the lateral (L)
GE or MGE (Fig. 2D). Together, these ﬁndings suggest that
ErbB4/PI3-kinase signaling may be important for migration of
interneurons toward and within the Cx (Fig. 2E).
PI3-Kinase and p35/Cdk5 Pathways Regulate
ErbB4-Mediated Chemotaxis of Cortical Interneurons
In Vitro
Earlier studies have shown the importance of NRG1/ErbB4
(Flames et al. 2004), PI3-kinase (Polleux et al. 2002), and p35/
Cdk5 (Rakic´ et al. 2009) in regulating cortical interneuron
migration; however, no relationship between them has yet been
described. PI3-kinases, a family of inositol lipid kinase signaling
Figure 2. Cortical interneurons upregulate Cyt1 expression in the pallium. (A) Schematic of ErbB4, illustrating domains and isoforms of the receptor (modiﬁed from Sundvall et al.
2008). JMa isoform, but not JMb, is susceptible to proteolytic cleavage. Cyt1 isoform contains a unique tyrosine residue (Y1056), absent in Cyt2, which serves as a binding site for
PI3-kinase. (B, C) RT-PCR. ErbB4 isoform expression in FACS-puriﬁed forebrain cells from GAD67GFP mice at the indicated time points. GFPGAD67(+) cells represent GABAergic
interneurons. (D) Immunoblots of protein lysates from the MGE, LGE, and Cx of E13.5 mice, showing phosphorylation (p) of ErbB4 on Y1056. ErbB4 and βAct serve as loading
controls. (E) Schematic, illustrating upregulation of Cyt1 as early-born interneurons (INs) depart from the subpallium, cross the PSB and enter the pallium. Cyt, cytoplasmic; JM,
juxtamembrane; RT, reverse transcriptase; TACE, tumor necrosis factor-α converting enzyme.
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enzymes, are divided into at least 3 distinct classes, I (A and B),
II, and III. Developing Cx as well as GAD67GFP(+) interneurons
express all but Class IB (Supplementary Table 2). Class IA PI3-
kinase (hereafter referred to as PI3-kinase) is the most abundant
member of the family in the developing Cx. It consists of a p110
catalytic subunit bound to 1 of 5 regulatory subunits, known as
p85s. Recruitment of the p85/p110 complex to receptors occurs
via p85 SH2 domains that bind preferentially to phosphorylated
tyrosine at the consensus YxxM motif. ErbB4 contains at least 2
YxxM motifs (Y950mvM and Y1056tpM); the Y1056tpM sequence
is Cyt1-speciﬁc and undoubtedly able to bind/activate PI3-
kinase (Fig. 3A; Kainulainen et al. 2000). Similarly, there are 2
potential consensus sequences [S/T]Px[K/H/R] for Cdk5 phos-
phorylation (S853PnH and T1152TPnH/R) on ErbB4 (Fig. 3A);
these were identiﬁed using the motif search engine Scansite
(http://scansite.mit.edu/).
The ability of NRG1β to induce chemotactic response in E13.5
cortical cells with altered either PI3-kinase or Cdk5 signaling
was analyzed using an in vitro chemotactic assay. Pretreatment
of wild-type (wt) cells with 10 μM LY294002 (PI3-kinase-speciﬁc
inhibitor) or 10 μM Roscovitine (Cdk5-speciﬁc inhibitor), dis-
solved in dimethyl sulfoxide (DMSO), signiﬁcantly decreased
their migration toward NRG1β compared with untreated or
DMSO-treated controls (LY294002: 89 ± 6; Roscovitine: 77 ± 6;
untreated: 250 ± 9; DMSO: 237 ± 7; Fig. 3B). The role of Cdk5
activity in NRG1β/ErbB4-directed migration was conﬁrmed in
E13.5 p35 litters; the chemotactic response to NRG1βwas strong
in wt cells (201 ± 10), but signiﬁcantly reduced in cells derived
from p35 KO (122 ± 9; Fig. 3C). Migration toward the negative
control (Neurobasal medium) was weak in both experimental
settings (Fig. 3B, 46 ± 1; Fig. 3C, wt: 66 ± 5; p35 KO: 57 ± 4).
These ﬁndings support the notion that the PI3-kinase and Cdk5
signaling pathways regulate NRG1β/ErbB4-dependent cortical
interneuron migration in vitro.
p35/Cdk5 Phosphorylates ErbB4 Receptor
on Threonine 1152
A number of studies have suggested a strong correlation
between Cdk5 activity and the ErbB receptor pathway (Fu et al.
2001, 2005; Li et al. 2003; Xie et al. 2004, 2007). To determine
whether p35/Cdk5 phosphorylates ErbB4 in vitro, we carried
out experiments using COS7 cells that naturally express Cdk5,
but not p35 or ErbB4. Cdk5 phosphorylates proteins containing
a [S/T]Px[K/H/R] site (Fig. 3A). We focused on threonine 1152
(T1152PmH/R) that lies in close proximity to Cyt1-speciﬁc
PI3-kinase-binding site Y1056. To initially test whether ErbB4 is
a substrate of Cdk5, we used a phosphospeciﬁc ab that recog-
nizes a minimal Cdk consensus site, phosphorylated threonine
adjacent to a proline (T(PO4)P), and discovered a stronger
ErbB4 phosphorylation in COS7 cells that co-expressed p35/
Cdk5 compared with other experimental conditions (Fig. 4A).
To further conﬁrm that ErbB4 is indeed phosphorylated by
Cdk5, we performed an in vitro p35/Cdk5 kinase assay using re-
combinant GST-fused ErbB4 fragments containing either the
native T1152 residue (GST-T) or an alanine point mutation
(T1152A), which was obtained by site-directed mutagenesis and
cannot be phosphorylated [GST-T(A); Fig. 4B]. GST and histone
1, an established substrate of Cdk5, were used as negative and
positive controls, respectively. This assay revealed a robust
phosphorylation by p35/Cdk5 of intact (GST-T), but not
mutated [GST-T(A)] ErbB4 fragments (Fig. 4C), identifying
ErbB4 as a Cdk5 substrate in vitro.
Cdk5 Promotes ErbB4/PI3-Kinase Activity In Vivo
Next, we hypothesized that Cdk5, by phosphorylating ErbB4
at T1152 in close proximity to PI3-kinase-binding site
(Y1056), could regulate ErbB4/PI3-kinase activity. To
explore this premise, we looked at the levels of ErbB4 phos-
phorylation on residue Y1056, as well as amounts of
Figure 3. PI3-kinase and p35/Cdk5 pathways regulate ErbB4-mediated chemotaxis of cortical cells in vitro. (A) Scansite software, predicting PI3-kinase-binding and Cdk5-targeted
phosphorylation sites of ErbB4. (B) Chemotactic response of Cx-derived cells, untreated or treated simultaneously with DMSO, Roscovitine (10 μM) or LY294002 (10 μM) for 30 min
prior to assay, to NRG1β. (C) Chemotactic response of Cx-derived cells, wt or p35-KO, to NRG1β. *P≤ 0.05, ***P≤ 0.005, t-test.
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phosphorylated Akt (S473), a downstream molecule in
ErbB4/PI3-kinase signaling cascade, in protein lysates of
E15.5 forebrain derived from Cdk5 litters. Decreased phos-
phorylation of ErbB4Y1056 and AktS473 in Cdk5 KO animals
compared with controls, conﬁrmed our hypothesis that
phosphorylation of ErbB4 by Cdk5 acts as a positive regula-
tor of ErbB4/PI3-kinase/Akt pathway in the Cx in vivo
(Fig. 4D).
Figure 4. p35/Cdk5 phosphorylation of ErbB4 in vitro and in vivo. (A) Immunoprecipitation (IP) of ErbB4myc from COS7 cell protein lysates; COS7 cells were co-transfected with
ErbB4myc, p35, and Cdk5. Immunoblots of ErbB4 IP protein extracts, revealing p35/Cdk5 phosphorylation of ErbB4 on threonine adjacent to proline (pTP; ﬁrst and second lanes vs.
third lane). Immunoblots of whole-cell protein lysates indicate expression of ErbB4, p35, and Cdk5. βAct serves as a loading control. (B) Schematic, illustrating GST-fusion ErbB4
fragments used in a kinase assay. (C) Kinase assay, showing phosphorylation of ErbB4 on T1152 by p35/Cdk5. GST and histone 1 serve as negative and positive controls,
respectively. (D) IP of ErbB4. Immunoblots of ErbB4 IP protein extracts and whole-cell protein lysates from the Cx of E15.5 mice, revealing decreased phosphorylation of ErbB4T1152,
ErbB4Y1056, and AktS473 in the Cdk5 KOs compared with littermate controls. ErbB4, Akt, and βAct serve as loading controls. (E, F) Schematic diagrams of ErbB4, showing
Cdk5-targeted (T1152; E) and PI3-kinase-binding (Y1056; F) phosphorylation sites recognized by pErbB4T1152 and pErbB4Y1056 antibodies, respectively. (G–R) Forebrain sections of a
GAD67GFP mouse embryo, at the indicated time points, immunostained for pErbB4T1152 and pErbB4Y1056 (red). GFPGAD67(+) cells (green) represent GABAergic interneurons. (G–J)
Dotted lines indicate the border between the pallium (p) and the subpallium (s). (K–P) show pErbB4T1152 and pErbB4Y1056 in a subset of cortical interneurons (arrows). Higher
magniﬁcations are shown in the insets. (Q) and (R) show that pErbB4T1152 and pErbB4Y1056 co-localize with β-III-tubulin (blue) in the proximal leading process (arrows) of cortical
interneurons. (S,T) Cdk5-phosphorylation and PI3K-binding sites in ErbB4 are well conserved across species. Bars, 200 μm (F–I), 50 μm (J–O), 20 μm (P,Q). A, alanine; GST,
glutathione S-transferase; SVZ, subventricular zone; Y, tyrosine.
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Phosphorylated ErbB4Y1056 and ErbB4T1152 are
Expressed in Cortical Interneurons
To evaluate the state of phosphorylation of ErbB4 in cortical
interneurons, we used phosphorylation-speciﬁc antibodies that
recognize Cdk5 consensus site (pErbB4T1152; Fig. 4E) or
Cyt1-speciﬁc PI3-kinase-binding site (pErbB4Y1056; Fig. 4F). To
test ab speciﬁcity, we co-transfected COS7 cells with plasmids
encoding either 1) ErbB4 (Cyt1), ErbB4ΔICD or mutated,
phosphorylation-resistant ErbB4Y1056F (pErbB4Y1056 ab) or 2)
p35/Cdk5 in addition to ErbB4 (Cyt1), ErbB4ΔICD or mutated,
phosphorylation-resistant ErbB4T1152A (pErbB4T1152 ab), and,
after 48-h incubation, treated the cells with 50 ng/mL of NRG1β
for 10 min. Immunoblotting of COS7 cells expressing intact or
ICD-lacking ErbB4 showed positive or negative signal, respect-
ively, for both phosphorylation-speciﬁc antibodies (Supplemen-
tary Fig. 3). However, while pErbB4T1152 ab did not recognize
mutated ErbB4T1152A (Supplementary Fig. 3), there was a
reduced signal in ErbB4Y1056F-expressing COS7 cells probed with
pErbB4Y1056 ab compared with positive control (ErbB4), indicat-
ing that this ab could identify other possible PI3-kinase-binding
consensus sites on the receptor (Chuu et al. 2008, Supplementary
Fig. 3). In developing forebrain, both phosphorylated forms of
ErbB4 were observed during the peak period of tangential
interneuron migration (Fig. 4G–R). Notably, pErbB4T1152 was de-
tected in postmitotic areas of both the subpallium and Cx
(Fig. 4H), while pErbB4Y1056 was prominently observed only at
the PSB and in the Cx (Figs 4J and 2C,D). Importantly, immuno-
histochemical analysis revealed the presence of both pErbB4T1152
and pErbB4Y1056 in approximately two-thirds of embryonic
GFPGAD67(+) cells (Fig. 4K–P and Supplementary Fig. 3). In
addition, pErbB4T1152 was detected in adult PV-positive inter-
neurons (Supplementary Fig. 3). At subcellular level, phosphory-
lated ErbB4 proteins were found to co-localize with β-III-tubulin,
a structural component of microtubules, particularly in the initial
segment of the interneuron leading process (Fig. 4Q,R). The fact
that the residues that characterize the consensus site for Cdk5
phosphorylation or PI3-kinase-binding of ErbB4 have been con-
served across species (Fig. 4S,T), and are in a state of phosphoryl-
ation in migrating interneurons, indicate that they might have an
important role in directing these cells from the subpallium
towards the cerebral Cx.
ErbB4 Regulates Cortical Interneuron Directionality
andMorphology via Cdk5 and PI3-Kinase Pathways
To test the function of phosphorylated ErbB4 in tangential
migration of cortical interneurons, we performed focal electro-
poration of MGE of the whole telencephalic hemisphere at
E13.5 (Fig. 5A), utilizing an array of different ErbB4 constructs
encoding the full-length (Cyt1) or genetically modiﬁed ErbB4,
with the aim of altering Cdk5 phosphorylation (Cyt1T1152A),
PI3-kinase-binding (Cyt1Y1056F and Cyt2), both Cdk5 and PI3-
kinase pathways (Cyt2T1152A) or entire ErbB4 intracellular sig-
naling (Cyt1ΔICD; Fig. 5A′). As a control, we used CAG-driven
EGFP vector (pCAG) that also served as a backbone for all
ErbB4 constructs (Fig. 5A′). To enhance the ﬂuorescent signal,
all plasmids were co-transfected with the CAG-driven tdToma-
to vector; the efﬁciency of the co-transfection, measured as a
ratio between GFP(+) and tdTomato(+) cells, was close to 1
(Supplementary Fig. 4). For all analyses, images of red tdToma-
to ﬂuorescence, converted to grayscale mode, were used.
The positions of MGE cells were assessed in whole hemi-
spheres and in forebrain sections 48-h postelectroporation.
While the medial view of the hemispheres revealed the site of
plasmid injection (MGE) (Fig. 5B–H), the lateral view allowed
us to observe the tangential spread of MGE cells in the entire
hemisphere (Fig. 5B′–H′). Images of forebrain sections, after
cutting the hemispheres coronally (Fig. 5B″–H″), depicted the
MGE cell migratory streams after passing the LGE; one running
toward the piriform cortex (PCx) and the other in the direction
of the neocortex (NCx; Fig. 5B″,K). The latter bifurcated at the
level of the PSB and gave rise to 2 streams running through the
PPL and IZ (Fig. 5B″,K). We observed a signiﬁcant departure
from the typical direction of migration in all experimental con-
ditions, except control (pCAG). Strikingly, overexpression of
intact ErbB4 (Cyt1) or ErbB4 modiﬁed to speciﬁcally suppress
Cdk5, PI3-kinase or both pathways caused a pronounced phe-
notype characterized by abnormal accumulation of MGE cells
in the PSB (Fig. 5C″–G″), and revealing an arcuate distribution
when the hemisphere was viewed laterally (Fig. 5C′–G′). These
MGE cells, on a coronal view and using a sector analysis
(Fig. 5I), were largely gathered in the ventral (V) Cx (including
the PSB) with fewer cells reaching the dorsal (D) Cx (Cyt1; V:
68 ± 2%; D: 32 ± 3%, 15 sections; Cyt1T1152A; V: 75 ± 2%; D:
25 ± 2%, 21 sections; Cyt1Y1056F; V: 78 ± 2%; D: 22 ± 3%, 18 sec-
tions; Cyt2; V: 79 ± 3%; D: 21 ± 2%, 19 sections; Cyt2T1152A; V:
80 ± 4%; D: 20 ± 1%, 13 sections; Fig. 5J,K) compared with con-
trols (pCAG; V: 57 ± 4%; D: 43 ± 3%, 23 sections; Fig. 5B′,B″,J,
K). It is worth noting that MGE cells overexpressing the intact
ErbB4 receptor (Cyt1) exhibited a milder directionality defect
compared with those which carried genetically modiﬁed
ErbB4 (Fig. 5C′,C″,J,K). A complete removal of the ICD of
ErbB4 (ErbB4ΔICD) in MGE cells led to a distinct phenotype in
which numerous ErbB4ΔICD-expressing cells failed to
advance from the MGE toward the LGE and Cx (Fig. 5H′,H″,K);
those that successfully migrated across the subpallium and into
the Cx, were most likely a subpopulation that did not express
ErbB4 in the ﬁrst place (Fig. 1C–F).
We found that genetic manipulation of the ErbB4 signaling
pathway in migrating MGE cells not only affected the direction
of movement, but also altered their morphologies. For mor-
phometric analysis, we focused on MGE cells situated at the
PSB and Cx, and observed 4 types of morphologies (Fig. 6A).
These appearances were perfectly in keeping with the descrip-
tions reported by Baudoin et al. (2008), who treated MGE cells
with nocodazole, a microtubule depolymerizing agent;
however, we adopted a slightly different descriptive terminol-
ogy. Most of the MGE cells exhibited typical polar morphology,
with either unbranched/non-bifurcated (type 1; Fig. 6A) or
branched/bifurcated (type 2; Fig. 6A) leading process. In
addition, we found polar MGE cells that had a short and thick
leading process with numerous protrusions emanating from
the main neurite; they had a brushy appearance, hence, we
termed them brush-like branched cells (type 3; Fig. 6A;
Baudoin et al. 2008). Polar MGE cells, normal or brush-like
branched, were present in both PSB and Cx. Finally, we ob-
served round cells that showed no polarity, and had numerous
extensions without forming a leading process (type 4; Fig. 6A);
these were found in the trajectory between MGE and Cx, with
the maximum accumulation at the PSB.
Alterations in the morphology of MGE cells, and the extent
of the transformation, depended on the speciﬁc ErbB4 signal-
ing pathway that was targeted (Fig. 6B–H). We ﬁrst examined
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the morphology of normal (type 1 and type 2; Fig. 6I) MGE
cells and found a signiﬁcant increase in the proportion of
branched/bifurcated (type 2) cells when they overexpressed
intact ErbB4 (Cyt1; type 1: 25 ± 1%; type 2: 75 ± 1%, 44 cells;
Fig. 6I) or genetically modiﬁed ErbB4 (Cyt1T1152A; type 1:
28 ± 2%; type 2: 72 ± 2%, 37 cells; Cyt1Y1056F; type 1: 25 ± 3%;
type 2: 75 ± 1%, 30 cells, Cyt2: type 1: 27 ± 2%; type 2: 73 ± 3%,
49 cells, Cyt2T1152A; type 1: 25 ± 1%; type 2: 75 ± 2%, 45 cells;
Fig. 6I) compared with control (pCAG; type 1: 39 ± 2%; type 2:
61 ± 1%, 39 cells; Fig. 6I). On the other hand, cells that ex-
pressed ErbB4ΔICD and found at the PSB exhibited mor-
phology similar to pCAG control (ErbB4ΔICD; type 1: 42 ± 1%;
type 2: 58 ± 1%, 21 cells; Fig. 6I). Interestingly, brush-like
branched (type 3) and round (type 4) cells were never ob-
served after transfection with control plasmid (pCAG) or
ErbB4ΔICD. However, the proportion of brush-like branched
(type 3) cells per entire polar cell population (type 1–3; Fig. 6J)
or the proportion of round (type 4) cells per total number of
examined cells (type 1–4; Fig. 6K) was signiﬁcantly increased
when MGE cells overexpressed intact or genetically modiﬁed
ErbB4. The extent of phenotypic change depended on the
ErbB4 signaling pathway(s) affected: mild (Cyt1; type 3:
12 ± 2%; type 4: 7 ± 1%, 232 cells), moderate (Cyt1T1152A; type
3: 23 ± 2%; type 4: 13 ± 2%, 298 cells) or severe (Cyt1Y1056F;
type 3: 33 ± 3%; type 4: 22 ± 1%, 212 cells; Cyt2; type 3:
32 ± 4%; type 4: 26 ± 2%, 145 cells; Cyt2T1152A; type 3: 33 ± 2%;
Figure 5. Different ErbB4 signaling pathways regulate tangential distribution of MGE cells. (A) Focal electroporation (EP) of control (pCAG) vector and ErbB4 constructs (expressed
from pCAG; A′), mixed with a CAG-driven tdTomato vector, into the E13.5 MGE of the whole-mouse telencephalic hemisphere. (B–H″) Fluorescent images of tdTomato, converted
to grayscale mode, 48-h post electroporation. (B–H) Medial view of the telencephalic hemisphere. Target symbol speciﬁes the site of electroporation (MGE). (B′–H′) Lateral view of
the telencephalic hemisphere, depicting the extent of tangential cell spread. The arcuate-shaped outline indicates the position of the PSB. (H′) Asterisk, MGE. (B″–H″) Coronal view
of the sectioned telencephalic hemisphere, showing the cortical migratory streams. A circle outlines the PSB. (I, J) Quantiﬁcation of the distribution of MGE cells in the Cx. (I)
Schematic, showing the Cx divided into 2 equal sectors, ventral (marked “V,” which includes the PSB) and dorsal (marked “D”). (J) A graph, showing the result of quantiﬁcation.
*P≤ 0.05, **P≤ 0.01, t-test comparing with pCAG. (K) Schematic representations of EP experiments: green lines depict the migratory routes of interneurons, rectangles indicate
the sites of abnormal accumulation of cells overexpressing ErbB4 plasmids (blue), and triangle (pink) signiﬁes the severity of the defect. gp, globus pallidus; NCx, neocortex; PCx,
paleocortex; Str, striatum. Bar, 250 μm.
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type 4: 25 ± 2%, 283 cells) (Fig. 6J–L). In summary, abolition of
ErbB4 phosphorylation by Cdk5 on residue T1152 had a pro-
found effect on polarity and directionality of MGE cells. Fur-
thermore, deﬁciency of both phosphorylation-sensitive
residues (Cdk5-targeted T1152 and PI3-kinase-binding Y1056
in Cyt2T1152A) had the same great impact as loss of Y1056
alone (Cyt1Y1056F and Cyt2) (Fig. 5L), conﬁrming that Cdk5
regulates ErbB4/PI3-kinase activity in migrating interneurons
(see Fig. 4D).
Loss of p35 and ErbB4 Alter the Number of Interneurons
That Reach the Cx via Different Mechanisms
Next, we compared interneuron phenotype in the developing
Cx of p35 and conditional ErbB4HER4heart KOs by using immu-
nohistochemistry with calbindin (CB) ab. In both KO mice we
detected signiﬁcantly fewer CB+ cells in the Cx compared with
control animals (WT: 49 ± 2 vs. p35 KO: 31 ± 1 at E13; ErbB4-
HER4heart, HET: 92 ± 3 vs. KO: 61 ± 2 at E13.5; Figs 7A–C, E–G
and 8M). However, the number of CB+ cells in the striatum at
E14.5 was increased in p35- and reduced in ErbB4-lacking
animals compared with control littermates (WT: 913 ± 33 vs. p35
KO: 1043 ± 30; ErbB4HER4heart, HET: 951 ± 31 vs. KO: 801 ± 29;
Fig. 7D,H). Therefore, in p35 KOs, interneurons failed to cross
the PSB and exhibited a “cortical migratory defect,” while in
ErbB4 conditional KOs these cells could not advance through
the LGE/striatum, thus showing a “GE migratory defect” (see
Fig. 5K). Besides, the levels of ErbBs, ligands and associated
molecules, assessed in a microarray study, remain normal in em-
bryonic p35 KOs (Supplementary Table 2), as well as cell pro-
liferation and cell death in the embryonic forebrain in both the
p35 and ErbB4HER4heart KOs (Supplementary Fig. 5).
Loss of p35 and ErbB4 Results in Reduction of a Subset
of Interneurons in the Adult Cx
Lastly, to determine whether reduction of interneurons in the
developing Cx of p35 and ErbB4HER4heart KOs was permanent,
we looked into numbers of adult cortical GABAergic neurons.
Immunohistochemical analysis of mice at P21, using GFP (in
p35GAD67GFP litters) or GABA (in ErbB4HER4heart litters) ab, re-
vealed a signiﬁcant decrease in the density of GABAergic cells
Figure 6. Leading process morphology defects of cortical interneurons after loss of Cdk5 and PI3-kinase ErbB4 signaling. (A–H) tdTomato ﬂuorescence, converted to grayscale,
revealing morphology of migrating interneurons, 48-h postelectroporation of E13.5 MGE with control (pCAG; B) and ErbB4 (C–H) constructs (see Fig. 5). (A) Four types of MGE
cell-leading process morphologies, observed at the PSB. (I) Percentage of unbranched (type 1) and branched (type 2) cells relative to total number of normal (type 1, 2) cells. (J)
Percentage of brush-like branched (type 3) and normal (type 1, 2) cells relative to total number of polar (type 1, 2, and 3) cells. (K) Percentage of round (type 4) and polar (type 1, 2,
and 3) cells relative to total cell number (type 1, 2, 3, and 4). (L) Schematic, indicating the severity of morphology defect in MGE cells in respect to altered ErbB4 signaling pathway.
*P≤ 0.05 (mild), **P≤ 0.01 (moderate), ***P≤ 0.005 (severe), t-test comparing against either control or Cyt1. Bar, 50 μm.
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in both the p35 and the ErbB4 KOs compared with controls
(p35: 361 ± 1 vs. 442 ± 1; Fig. 8A–C; ErbB4HER4heart: 399 ± 7 vs.
487 ± 9; Fig. 8D). We next wondered what speciﬁc classes of
interneurons were affected by loss of p35 or ErbB4, and discov-
ered that these 2 genes could control the development of the
same, but also different interneuron subpopulations. While
there was a signiﬁcant reduction in density of PV-containing
interneurons in both KOs compared with control littermates
(p35: 175 ± 1 vs. 204 ± 1; Fig. 8E–G,M; ErbB4HER4heart:
168 ± 10 vs. 218 ± 15; Fig. 8H,M), we observed fewer SST+ cells
only in p35 KO animals compared with controls (120 ± 5 vs.
146 ± 1; Fig. 8I–L,M). In addition, loss of either p35 or ErbB4
gene did not affect the calretinin (CalR) interneuron numbers
(data not shown; Fig. 8M) or speciﬁcation of interneuron sub-
types (Supplementary Fig. 6).
Discussion
We discovered that cortical interneurons utilize speciﬁc ErbB4-
mediated signaling pathways to regulate their motility while
coursing toward and through forebrain areas enriched in
NRG1, NRG3, and HB-EGF. Explicitly, we found that p35/
Cdk5 plays an important role in their directed migration by
phosphorylating ErbB4 and subsequently modulating one of
the canonical ErbB4 signaling pathways, PI3-kinase/Akt.
Differential Expression of ErbB4 Isoforms in Migrating
Cortical Interneurons
We found that ErbB4 is the only ErbB family member ex-
pressed by migrating cortical interneurons. This gene encodes
2 distinct cytoplasmic isoforms that can selectively regulate
growth factor responses by activating different signaling
pathways (Junttila et al. 2000). Published evidence suggests
that isoform Cyt1, unlike Cyt2, activates the PI3-kinase/Akt
pathway; both isoforms can stimulate the MAPK pathway
(Sundvall et al. 2008).
Interneurons born in the MGE migrate through the subpal-
lium to reach the Cx and differentiate predominantly into PV-
and SST-positive subtypes (Fishell and Rudy 2011). We
showed that the Cyt2 isoform is present in interneurons as they
leave the MGE and travel through a permissive corridor con-
taining LGE-derived cells that express a membrane-bound
NRG1-CRD (type III) (Calaora et al. 2001; Assimacopoulos
et al. 2003; Flames et al. 2004; López-Bendito et al. 2006).
Therefore, Cyt2 is most likely required for their migration
through the subpallium by haptotaxis via cell-to-cell inter-
actions with NRG1-CDR+ cells (Supplementary Fig. 8 and
Table 3). On the other hand, early-born migrating interneurons
(E12.5/13.5) do not express Cyt1 until they reach the PSB, a cor-
tical signaling center also known as antihem (Assimacopoulos
et al. 2003), the “angle” region (López-Bendito et al. 2006) or
the ventral pallium (Subramanian et al. 2009), where they
encountertwo ErbB4 ligands, NRG1-Ig (secreted; type I and II;
Flames et al. 2004) and NRG3 (Assimacopoulos et al. 2003).
Therefore, Cyt1 regulates interneuron-directed chemotaxis
toward cortical sources of ErbB4 ligands (Supplementary
Fig. 8 and Table 3). Interneurons with altered ErbB4/PI3-
kinase activity, as shown in this study, can pass through the
MGE/LGE permissive corridor, but their migration is random,
the leading process anomalous, and many cannot traverse the
PSB. Yet, in the event of complete loss of ErbB4 or NRG1 sig-
naling in the developing forebrain, a proportion of these cells
fail to advance and stay conﬁned to the MGE (this study;
Flames et al. 2004). Therefore, distinct ErbB4 pathways are
Figure 7. Loss of p35 and ErbB4 alter the number of interneurons that reach the Cx via different mechanisms. (A, B, E, F) Embryonic forebrain sections of indicated genotypes and
ages, immunostained for CB. The LGE/Cx junction is shown within a box outline. (C, D, G, F) Quantiﬁcation of the number of CB cells in the Cx and striatum (Str) of control (black)
and indicated KO (white) animals. *P≤ 0.05, ***P≤ 0.005, t-test. Bar, 200 μm.
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required for tangential interneuron migration through the de-
veloping forebrain (Supplementary Fig. 8 and Table 3). To
further address the exact role of different ErbB4 isoforms and
accompanied signaling pathways in interneuron migration,
electroporation of ErbB4HER4heart animals with either Cyt1 or
Cyt2 should be performed.
ErbB4 as a Cdk5 Substrate
We provide the ﬁrst evidence that Cdk5 phosphorylates ErbB4
and facilitates cell migration by modifying ErbB4 signaling.
Other ErbBs are known substrates of Cdk5; speciﬁcally, Cdk5
phosphorylates ErbB2 and ErbB3 at the neuromuscular junc-
tion (NMJ; Fu et al. 2001, 2005) and in perinatal cortical
neurons (Li et al. 2003) regulating neurotransmission and neur-
onal survival, respectively.
Cdk5 phosphorylates ErbB4 at T1152, situated in close
proximity to the PI3-kinase-binding site (Y1056), and in turn
promotes ErbB4 tyrosine phosphorylation. Loss of Cdk5 func-
tion suppresses ErbB4 Y1056 phosphorylation and sub-
sequently PI3-kinase activity. Recent studies have also shown
that p35/Cdk5 positively controls ErbB2 (Fu et al. 2005) and
PI3-kinase/Akt (Li et al. 2003) kinase activity by phosphorylat-
ing ErbB2/ErbB3. In contrast, phosphorylation of AATYK1
(apoptosis-associated tyrosine kinase 1) by Cdk5 represses its
tyrosine phosphorylation (Tsutsumi et al. 2010). It is not clear
how exactly Cdk5 controls tyrosine phosphorylation, directly,
by changing the conformation of ErbB4, or via other kinases
(e.g., Src family kinases; Tsutsumi et al. 2010). Nevertheless,
our study demonstrates the importance of ErbB4 phosphoryl-
ation by Cdk5 in cortical interneuron migration (Supplemen-
tary Fig. 8).
ErbB4, PI3-Kinase, Cdk5, and Cytoskeleton in Neuronal
Migration
In cortical interneurons, leading process dynamics and, ac-
cordingly, cell polarity and directionality most likely rely on a
microtubule network (Baudoin et al. 2008), while nuclear
translocation toward the selected leading process and, conse-
quently, locomotion are primarily driven by actomyosin forces
applied to the rear of the nucleus (Bellion et al. 2005; Martini
and Valdeolmillos 2010). We have previously demonstrated
that lack of Cdk5 activity in p35 KOs alters leading process
Figure 8. Loss of p35 and ErbB4 results in reduction of a subset of interneurons in the adult Cx. (A, B, E, F, I, J) Sections of adult (P21) somatosensory Cx of control and p35 KO
mouse, immunostained for GFP, PV, and SST, indicating the quantity and distribution of interneurons. (A, B) Vertical line speciﬁes the width of the Cx and white matter. Roman
numerals designate cortical layers in control animals. Loss of p35 alters cortical laminar organization (layers are inverted compared with controls), and white matter is histologically
undetectable due to misguided ﬁbers that run through the center of the Cx (Rakić et al. 2006). (C, D, G, H, K, L) Quantiﬁcation of the number of GFPGAD67, PV, and SST interneurons
in the Cx of control (black) and indicated KO (white) animals. *P≤ 0.05, ***P≤ 0.005, t-test. (M) Schematic, showing loss of embryonic and postnatal interneurons in p35 and
ErbB4 KOs compared with controls. Bar, 50 μm.
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morphology in migrating cortical interneurons. Speciﬁcally,
p35-deﬁcient interneurons display a signiﬁcant increase in
branching while entering the Cx from ventral telencephalic
sources. Similarly, motor axon projections at the NMJ (Fu et al.
2005) and migrating pyramidal neurons in the Cx (Gupta et al.
2003; Ohshima et al. 2007) have profuse and anomalous
branching patterns in p35- or Cdk5-KOs. Furthermore,
p35-deﬁcient interneurons or pyramidal cells exhibit impaired
migration (this study; Gupta et al. 2003; Rakic´ et al. 2009).
Here, we present original evidence that interdependent signal-
ing pathways, PI3-kinase and Cdk5, play a key role in ErbB4-
mediated interneuron migration. Namely, alteration in ErbB4 sig-
naling, due to lack of PI3-kinase binding, Cdk5 phosphorylation
or both, impair directionality and leading process morphology,
and almost completely mimics the phenotype seen when inter-
neurons are treated with nocodazole, a microtubule destabilizing
drug (Baudoin et al. 2008). The majority of affected cells either
1) have a leading process that is shortened and thickened with
numerous tiny protrusions (brush-like) or 2) lose their polarity
and exhibit a round and multipolar appearance. In contrast, a
small percentage of cells maintained normal polarity and neurite
length, but were seen to bifurcate more extensively; this is remi-
niscent of the phenotype observed when Doublecortin, a micro-
tubule stabilizing protein, is knocked out (Kappeler et al. 2006;
Friocourt et al. 2007). Therefore, different alterations in pathways
controlling microtubule stability may lead to diverse abnormal-
ities in interneuron leading process dynamics.
Loss of ErbB4 or p35 in mice gives rise to a similar phenotype
characterized by alteration in tangential migration and a
reduction in the number of interneurons in the adult Cx (this
study; Flames et al. 2004; Rakic´ et al. 2009). This phenotype is,
however, achieved by distinct mechanisms; ErbB4 (Cyt2
isoform) is needed for MGE to LGE interneuron migration via
yet unknown signaling mechanism(s), while p35/Cdk5 plays a
role in ErbB4-mediated migration as interneurons enter the Cx
and express the Cyt1 isoform. It is possible that Cdk5-dependent
PI3-kinase activity in ErbB4-expressing interneurons is necess-
ary to determine direction of their movement, but also to
mediate nucleokinesis, as some cells (∼20%) never make it to
the Cx in p35 KOs. In line with this, it has been shown that PI3-
kinase regulates small Rho GTPases (Waite and Eickholt 2010)
and, yet, RhoA/ROCK signaling contributes to cell polarity and
migration by affecting both microtubule stability and actomyo-
sin contractility (Takesono et al. 2010). Interestingly, ErbB4 has
been found in close proximity to microtubules in adult inter-
neurons (Mechawar et al. 2007). Here, we observed that ErbB4
co-localizes with β-III-tubulin, a neuron-speciﬁc tubulin that
makes up microtubules, in migrating interneurons. Further elec-
tron microscopic and biochemical binding studies are needed to
reveal whether ErbB4 directly associates with the cytoskeleton
and/or cytoskeletal regulatory molecules, such as p35/Cdk5,
during the process of cytokinesis.
In summary, our results illustrate the importance of
co-activation of PI3-kinase/Akt and p35/Cdk5 signaling path-
ways at the interface between pallium and subpallium in sup-
porting migration of ErbB4+ interneurons towards cortical
sources of ErbB4 ligands. The abnormal interneuron migration
seen in KO mice lacking either ErbB4 or p35 results in a per-
manent absence of certain interneuron subtypes (PV+ or PV+
and SST+ cells, respectively) which may promote the formation
of aberrant neuronal circuitry underpinning clinically-deﬁned
neurodevelopmental disorders. Indeed, interference in NRG1/
ErbB4 and p35/Cdk5 signaling has been associated with epi-
lepsy (Dhavan and Tsai 2001; Li et al. 2011; Tan et al. 2011)
and schizophrenia (Engmann et al. 2011; Marín 2012), in both
mice and humans. Here, we have provided strong evidence of
a link between the 2 pathways with respect to interneuron
migration. Both ErbB4 and Cdk5 signaling are critical players
in synapse formation, and further investigation of their inter-
action in this respect is likely to be important for the elucida-
tion of pathological circuitries associated with different clinical
correlates.
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Supplementary material can be found at: http://www.cercor.
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